Jin Medical International Ltd.
ZJYLNasdaq
$1.90
0.0%Jul 17 close · end-of-day
Price
1Y↑ +197.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$297.4M
Enterprise Value
$294.1M
P/E
190.0
P/S
14.4
P/B
10.0
EV/EBITDA
345.4
PEG
—
FCF Yield
-1.3%
Dividend Yield
—
Revenue (TTM)
$20.7M
Net Income (TTM)
$1.2M
Free Cash Flow (TTM)
-$3.7M
Gross Margin
29.2%
Operating Margin
2.9%
Net Margin
5.8%
ROE
4.0%
ROIC
2.0%
Debt / Equity
0.6
Net Cash
$3.3M
Return 1Y
+194.6%
Company profile
The China-based VIE, Changzhou Zhongjin, and its subsidiaries, design and manufacture wheelchairs and living aids products for people with disabilities, the elderly, and people recovering from injury. Our principal executive offices are located at No. 33 Lingxiang Road, Wujin District, Changzhou City, Jiangsu Province People’s Republic of China. Our registered office in the Cayman Islands is located at P.O. Box 31119, Grand Pavilion, Hibiscus Way,802 West Bay Road, Grand Cayman, KY1-1205 Cayman Islands, Cayman Islands.We maintain a corporate website at www.zhjmedical.com. Our legal name is JIN MEDICAL INTERNATIONAL LTD., and we operate our business under the commercial name “Jin Med”. Our agent for service of process in the United States is Cogency Global Inc., 122 E. 42nd Street, 18th Floor, New York, NY.
- CEO
- Erqi Wang
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Website
- www.zhjmedical.com/
Earnings
No reported earnings periods on file.
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $20.8M | $19.2M | $19.8M | $23.5M | $20.7M |
| Gross profit | $6.4M | $6.2M | $6.8M | $9.5M | $6.0M |
| Operating income | $2.6M | $2.1M | $2.9M | $3.6M | $608,182.00 |
| Net income | $2.6M | $2.7M | $2.9M | $3.7M | $1.2M |
| Diluted EPS | $0.02 | $0.02 | $0.02 | $0.02 | $0.01 |
| Operating cash flow | $5.8M | $1.6M | $3.1M | -$1.2M | $2.9M |
| Free cash flow | $5.8M | $1.5M | $3.0M | -$1.4M | -$3.7M |
| Gross margin | 30.6% | 32.3% | 34.2% | 40.4% | 29.2% |
| Operating margin | 12.7% | 11.1% | 14.5% | 15.5% | 2.9% |
| Net margin | 12.7% | 14.1% | 14.5% | 15.6% | 5.8% |
No quarterly data.
Company news
Jan 26, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.